AUA 2013 - Poster: Safety and changes in laboratory parameters associated with sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 2 ProACT study

SAN DIEGO, CA USA (UroToday.com) - Presented by Thomas Gardner,¹ Daniel Petrylak,² John Corman,³ Simon Hail,⁴ Ralph Weinstein,⁵ Robert Sims,⁶ Todd DeVries,⁶ and Celestia Higano⁷ at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA

¹Urology Indiana University Health, Indianapolis, IN, USA; ²Yale Cancer Center, New Haven, CT, USA; ³Virginia Mason Medical Center, Seattle, WA, USA; ⁴Mount Sinai School of Medicine, New York, NY, USA; ⁵US Oncology, Portland, OR, USA; ⁶Dendreon Corporation, Seattle, WA, USA; ⁷School of Medicine, University of Washington, Seattle, WA, USA

View Full AUA 2013 Coverage